Chopra et al., 2019 - Google Patents
Biophysical characterization and drug delivery potential of exosomes from human Wharton's jelly-derived mesenchymal stem cellsChopra et al., 2019
View PDF- Document ID
- 4776800768237774854
- Author
- Chopra N
- Dutt Arya B
- Jain N
- Yadav P
- Wajid S
- Singh S
- Choudhury S
- Publication year
- Publication venue
- ACS omega
External Links
Snippet
Cell-derived exosomes (30–200 nm) as biological “nanocarriers” have attracted a great deal of interest for therapeutic applications due to their ability to internalize in in vivo biological systems (ie, cells). Although they can be harvested from various sources including stem …
- 210000001808 Exosomes 0 title abstract description 375
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chopra et al. | Biophysical characterization and drug delivery potential of exosomes from human Wharton’s jelly-derived mesenchymal stem cells | |
| Sadeghi et al. | Exosome engineering in cell therapy and drug delivery | |
| Di Rocco et al. | Towards therapeutic delivery of extracellular vesicles: strategies for in vivo tracking and biodistribution analysis | |
| Zhang et al. | Exosomes: biogenesis, biologic function and clinical potential | |
| He et al. | Exosomal targeting and its potential clinical application | |
| Tkach et al. | Why the need and how to approach the functional diversity of extracellular vesicles | |
| Piffoux et al. | Modification of extracellular vesicles by fusion with liposomes for the design of personalized biogenic drug delivery systems | |
| Park et al. | Engineering the surface of therapeutic “living” cells | |
| Armstrong et al. | Re-engineering extracellular vesicles as smart nanoscale therapeutics | |
| Qi et al. | Blood exosomes endowed with magnetic and targeting properties for cancer therapy | |
| Li et al. | Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke | |
| Yang et al. | Encapsulation of individual living cells with enzyme responsive polymer nanoshell | |
| Shen et al. | Tracking exosomes in vitro and in vivo to elucidate their physiological functions: implications for diagnostic and therapeutic nanocarriers | |
| Li et al. | Silica nanorattle–doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy | |
| Gomes et al. | Efficient pro-survival/angiogenic miRNA delivery by an MRI-detectable nanomaterial | |
| Cesi et al. | Transferring intercellular signals and traits between cancer cells: extracellular vesicles as “homing pigeons” | |
| Geng et al. | Recent advancement and technical challenges in developing small extracellular vesicles for cancer drug delivery | |
| Huang et al. | Research advances of engineered exosomes as drug delivery carrier | |
| Jia et al. | Recent progress of extracellular vesicle engineering | |
| Thomas et al. | Exosomes: biological pharmaceutical nanovectors for theranostics | |
| Desai et al. | “Bioinspired” membrane-coated nanosystems in cancer theranostics: a comprehensive review | |
| Macedo-Pereira et al. | Digging the intercellular crosstalk via extracellular vesicles: may exosomes be the drug delivery solution for target glioblastoma? | |
| Zhou et al. | The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer | |
| Bharti et al. | Nanotechnology in stem cell research and therapy | |
| Nag et al. | Clinical theranostics trademark of exosome in glioblastoma metastasis |